DIAGNOSTIC INSIGHTS FOR LIFE™
CND has launched the Syn-One Test® to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.
Introducing the Syn-One Test® from CND Life Sciences
Offering physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy.
CLIA-Certified Pathology Lab
Dedication to Science & Research
Quality & Reliability at Our Core
Clarity and Confidence of Syn-One
Having objective, visual proof of a disease process can be invaluable for physicians and patients. That’s why CND Life Sciences developed the Syn-One Test as a way to actually see the presence of abnormal alpha-synuclein in the skin–an important marker for Parkinson’s disease and other disorders known as synucleinopathies.
Our Commitment to Patients
We did not invent the saying “knowledge is power,” but we subscribe to this philosophy as part of our mission. Patients and caregivers rely on physicians to make vital clinical judgments every day, and we are committed to providing reliable diagnostic technologies and useful insights that help optimize care.
Learn more about what drives us.